{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:57:08Z","timestamp":1792637828139,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22175096"],"award-info":[{"award-number":["22175096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64020-x","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:01:04Z","timestamp":1760011264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Size-variable self-feedback nanomotors for glioblastoma therapy via mitochondrial mineralization"],"prefix":"10.1038","volume":"16","author":[{"given":"Tiantian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiluan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4085-3414","authenticated-orcid":false,"given":"Chun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"64020_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/v15020547","volume":"15","author":"A Hamad","year":"2023","unstructured":"Hamad, A., Yusubalieva, G. M., Baklaushev, V. P., Chumakov, P. M. & Lipatova, A. V. Recent developments in glioblastoma therapy: oncolytic viruses and emerging future strategies. Viruses 15, 547 (2023).","journal-title":"Viruses"},{"key":"64020_CR2","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.3390\/cancers15072116","volume":"15","author":"SSK Yalamarty","year":"2023","unstructured":"Yalamarty, S. S. K. et al. Mechanisms of resistance and current treatment options for glioblastoma multiforme (GBM). Cancers 15, 2116 (2023).","journal-title":"Cancers"},{"key":"64020_CR3","doi-asserted-by":"publisher","first-page":"113999","DOI":"10.1016\/j.addr.2021.113999","volume":"179","author":"J Karlsson","year":"2021","unstructured":"Karlsson, J., Luly, K. M., Tzeng, S. Y. & Green, J. J. Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies. Adv. Drug Deliv. Rev. 179, 113999 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"64020_CR4","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp, R. et al. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA. 318, 2306\u20132316 (2017).","journal-title":"JAMA."},{"key":"64020_CR5","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-18-3643","volume":"25","author":"A Idbaih","year":"2019","unstructured":"Idbaih, A. et al. Safety and feasibility of repeated and transient blood\u2013brain barrier disruption by pulsed ultrasound in patients with recurrent glioblastoma. Clin. Cancer Res. 25, 3793\u20133801 (2019).","journal-title":"Clin. Cancer Res."},{"key":"64020_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11060-020-03408-9","volume":"151","author":"RS D'Amico","year":"2021","unstructured":"D'Amico, R. S., Aghi, M. K., Vogelbaum, M. A. & Bruce, J. N. Convection-enhanced drug delivery for glioblastoma: a review. J. Neurooncol. 151, 415\u2013427 (2021).","journal-title":"J. Neurooncol."},{"key":"64020_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","volume":"9","author":"R Ma","year":"2023","unstructured":"Ma, R., Li, Z., Chiocca, E. A., Caligiuri, M. A. & Yu, J. The emerging field of oncolytic virus-based cancer immunotherapy. Trends Cancer 9, 122\u2013139 (2023).","journal-title":"Trends Cancer"},{"key":"64020_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26003-6","volume":"12","author":"B Xu","year":"2021","unstructured":"Xu, B. et al. An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma. Nat. Commun. 12, 5908 (2021).","journal-title":"Nat. Commun."},{"key":"64020_CR9","doi-asserted-by":"publisher","first-page":"23001","DOI":"10.1021\/acsnano.4c04553","volume":"18","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Boost infiltration and activity of T cells via inhibiting ecto-5\u2032-nucleotidase (CD73) immune checkpoint to enhance glioblastoma immunotherapy. ACS Nano 18, 23001\u201323013 (2024).","journal-title":"ACS Nano"},{"key":"64020_CR10","first-page":"624","volume":"5","author":"GB Kim","year":"2020","unstructured":"Kim, G. B. et al. High-affinity mutant Interleukin-13 targeted CAR T cells enhance delivery of clickable biodegradable fluorescent nanoparticles to glioblastoma. Bioact. Mater. 5, 624\u2013635 (2020).","journal-title":"Bioact. Mater."},{"key":"64020_CR11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s43018-024-00730-3","volume":"5","author":"KPM Suijkerbuijk","year":"2024","unstructured":"Suijkerbuijk, K. P. M., van Eijs, M. J. M., van Wijk, F. & Eggermont, A. M. M. Clinical and translational attributes of immune-related adverse events. Nat. Cancer 5, 557\u2013571 (2024).","journal-title":"Nat. Cancer"},{"key":"64020_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neo.2015.02.002","volume":"17","author":"H Wang","year":"2015","unstructured":"Wang, H. et al. The challenges and the promise of molecular targeted therapy in malignant gliomas. Neoplasia 17, 239\u2013255 (2015).","journal-title":"Neoplasia"},{"key":"64020_CR13","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1073\/pnas.1014480108","volume":"108","author":"O Keunen","year":"2011","unstructured":"Keunen, O. et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc. Natl. Acad. Sci. USA 108, 3749\u20133754 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64020_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1200\/jco.2007.25.18_suppl.2001","volume":"25","author":"T Batchelor","year":"2007","unstructured":"Batchelor, T. et al. A phase II trial of AZD2171 (cediranib), an oral pan-VEGF receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J. Clin. Oncol. 25, 18 (2007).","journal-title":"J. Clin. Oncol."},{"key":"64020_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ccr.2006.11.021","volume":"11","author":"TT Batchelor","year":"2007","unstructured":"Batchelor, T. T. et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11, 83\u201395 (2007).","journal-title":"Cancer Cell"},{"key":"64020_CR16","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/neuonc\/noae074","volume":"26","author":"P O\u2019Hare","year":"2024","unstructured":"O\u2019Hare, P. et al. Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: a modified delphi approach to build international consensus-based definitions-international pediatric low-grade glioma coalition. Neuro Oncol. 26, 1357\u20131366 (2024).","journal-title":"Neuro Oncol."},{"key":"64020_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202303596","volume":"33","author":"X Chang","year":"2023","unstructured":"Chang, X. et al. Precise starving therapy via physiologically dependent photothermal conversion promoted mitochondrial calcification based on multi-functional gold nanoparticles for effective tumor treatment. Adv. Funct. Mater. 33, 2303596 (2023).","journal-title":"Adv. Funct. Mater."},{"key":"64020_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41586-020-2309-6","volume":"582","author":"M Fan","year":"2020","unstructured":"Fan, M. et al. Structure and mechanism of the mitochondrial Ca2+ uniporter holocomplex. Nature 582, 129 (2020).","journal-title":"Nature"},{"key":"64020_CR19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41580-018-0052-8","volume":"19","author":"C Giorgi","year":"2018","unstructured":"Giorgi, C., Marchi, S. & Pinton, P. The machineries, regulation and cellular functions of mitochondrial calcium. Nat. Rev. Mol. Cell Biol. 19, 713\u2013730 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"64020_CR20","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/anie.201915826","volume":"60","author":"SS Liew","year":"2021","unstructured":"Liew, S. S. et al. Smart design of nanomaterials for mitochondria-targeted nanotherapeutics. Angew. Chem. Int. Ed. 60, 2232\u20132256 (2021).","journal-title":"Angew. Chem. Int. Ed."},{"key":"64020_CR21","doi-asserted-by":"publisher","first-page":"133850","DOI":"10.1016\/j.cej.2021.133850","volume":"433","author":"X Guo","year":"2022","unstructured":"Guo, X. et al. Intelligent gold nanoparticles for synergistic tumor treatment via intracellular Ca2+ regulation and resulting on-demand photothermal therapy. Chem. Eng. J. 433, 133850 (2022).","journal-title":"Chem. Eng. J."},{"key":"64020_CR22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cclet.2015.04.009","volume":"26","author":"X Huang","year":"2015","unstructured":"Huang, X. & Huang, Y. Solubilization of organic compounds by arginine-derived polymers. Chin. Chem. Lett. 26, 636\u2013640 (2015).","journal-title":"Chin. Chem. Lett."},{"key":"64020_CR23","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1021\/bm301351e","volume":"13","author":"Y Kim","year":"2012","unstructured":"Kim, Y., Binauld, S. & Stenzel, M. H. Zwitterionic guanidine-based oligomers mimicking cell-penetrating peptides as a nontoxic alternative to cationic polymers to enhance the cellular uptake of micelles. Biomacromolecules 13, 3418\u20133426 (2012).","journal-title":"Biomacromolecules"},{"key":"64020_CR24","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1021\/bc200666u","volume":"23","author":"S Bersani","year":"2012","unstructured":"Bersani, S. et al. Star-like oligo-arginyl-maltotriosyl derivatives as novel cell-penetrating enhancers for the intracellular delivery of colloidal therapeutic systems. Bioconjug. Chem. 23, 1415\u20131425 (2012).","journal-title":"Bioconjug. Chem."},{"key":"64020_CR25","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1021\/acsnano.2c08434","volume":"17","author":"H Fang","year":"2023","unstructured":"Fang, H. et al. In situ polymerization of zwitterions on therapeutic proteins to enable their effective oral delivery. ACS Nano 17, 1128\u20131143 (2023).","journal-title":"ACS Nano"},{"key":"64020_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.actbio.2017.08.048","volume":"65","author":"DQ Wu","year":"2018","unstructured":"Wu, D. Q. et al. Synthesis and characterization of arginine-NIPAAm hybrid hydrogel as wound dressing: in vitro and in vivo study. Acta Biomater. 65, 305\u2013316 (2018).","journal-title":"Acta Biomater."},{"key":"64020_CR27","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s11426-023-1837-7","volume":"67","author":"T Li","year":"2024","unstructured":"Li, T. et al. Chemotactic nanomotor for multimodal combined therapy of glioblastoma. Sci. China Chem. 67, 1277\u20131288 (2024).","journal-title":"Sci. China Chem."},{"key":"64020_CR28","doi-asserted-by":"publisher","first-page":"7032","DOI":"10.1039\/D2BM00952H","volume":"10","author":"S Zhou","year":"2022","unstructured":"Zhou, S. et al. Dendritic lipopeptide liposomes decorated with dual-targeted proteins. Biomater. Sci. 10, 7032\u20137041 (2022).","journal-title":"Biomater. Sci."},{"key":"64020_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jcis.2017.08.079","volume":"508","author":"Q Liu","year":"2017","unstructured":"Liu, Q., Hu, J., Whittaker, M. R., Davis, T. P. & Boyd, B. J. Nitric oxide-sensing actuators for modulating structure in lipid-based liquid crystalline drug delivery systems. J. Colloid Interf. Sci. 508, 517\u2013524 (2017).","journal-title":"J. Colloid Interf. Sci."},{"key":"64020_CR30","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.1002\/anie.201403147","volume":"53","author":"J Hu","year":"2014","unstructured":"Hu, J. et al. Biomimetic polymers responsive to a biological signaling molecule: nitric oxide triggered reversible self-assembly of single macromolecular chains into nanoparticles. Angew. Chem. Int. Ed. 53, 7779\u20137784 (2014).","journal-title":"Angew. Chem. Int. Ed."},{"key":"64020_CR31","doi-asserted-by":"publisher","first-page":"2206654","DOI":"10.1002\/adma.202206654","volume":"34","author":"T Li","year":"2022","unstructured":"Li, T. et al. A universal chemotactic targeted delivery strategy for inflammatory diseases. Adv. Mater. 34, 2206654 (2022).","journal-title":"Adv. Mater."},{"key":"64020_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35709-0","volume":"14","author":"H Chen","year":"2023","unstructured":"Chen, H. et al. A nitric-oxide driven chemotactic nanomotor for enhanced immunotherapy of glioblastoma. Nat. Commun. 14, 941 (2023).","journal-title":"Nat. Commun."},{"key":"64020_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/scirobotics.aaz9519","volume":"6","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Dual-responsive biohybrid neutrobots for active target delivery. Sci. Robot. 6, eaaz9519 (2021).","journal-title":"Sci. Robot."},{"key":"64020_CR34","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1021\/acs.nanolett.5b03100","volume":"15","author":"X Ma","year":"2015","unstructured":"Ma, X. et al. Enzyme-powered hollow mesoporous Janus nanomotors. Nano Lett. 15, 7043\u20137050 (2015).","journal-title":"Nano Lett."},{"key":"64020_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh1736","volume":"9","author":"X Peng","year":"2023","unstructured":"Peng, X. et al. Autonomous metal-organic framework nanorobots for active mitochondria-targeted cancer therapy. Sci. Adv. 9, eadh1736 (2023).","journal-title":"Sci. Adv."},{"key":"64020_CR36","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1021\/acsnano.3c00548","volume":"17","author":"Z Yang","year":"2023","unstructured":"Yang, Z. et al. Ultrasmall enzyme-powered Janus nanomotor working in blood circulation system. ACS Nano 17, 6023\u20136035 (2023).","journal-title":"ACS Nano"},{"key":"64020_CR37","doi-asserted-by":"publisher","first-page":"11019","DOI":"10.1021\/jacs.2c12219","volume":"145","author":"Z Sun","year":"2023","unstructured":"Sun, Z. et al. Self-propelled Janus nanocatalytic robots guided by magnetic resonance imaging for enhanced tumor penetration and therapy. J. Am. Chem. Soc. 145, 11019\u201311032 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"64020_CR38","doi-asserted-by":"publisher","first-page":"8086","DOI":"10.1021\/acs.nanolett.1c02441","volume":"21","author":"Y Ye","year":"2021","unstructured":"Ye, Y. et al. Apoptotic tumor DNA activated nanomotor chemotaxis. Nano Lett. 21, 8086\u20138094 (2021).","journal-title":"Nano Lett."},{"key":"64020_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mvr.2005.07.002","volume":"70","author":"MF Meyer","year":"2005","unstructured":"Meyer, M. F. et al. Lack of a difference in increased capillary blood cell velocity in the skin over proximal interphalangeal joints between rheumatoid arthritis and osteoarthritis. Microvasc. Res. 70, 1\u20136 (2005).","journal-title":"Microvasc. Res."},{"key":"64020_CR40","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/molecules26041169","volume":"26","author":"SS Chelliah","year":"2021","unstructured":"Chelliah, S. S., Paul, E. A. L., Kamarudin, M. N. A. & Parhar, I. Challenges and perspectives of standard therapy and drug development in high-grade gliomas. Molecules 26, 1169 (2021).","journal-title":"Molecules"},{"key":"64020_CR41","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.3390\/ijms17121998","volume":"17","author":"K-H Lin","year":"2016","unstructured":"Lin, K.-H. et al. Enhancing anticancer effect of gefitinib across the blood-brain barrier model using liposomes modified with one \u03b1-helical cell-penetrating peptide or glutathione and tween 80. Int. J. Mol. Sci. 17, 1998 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"64020_CR42","doi-asserted-by":"publisher","first-page":"9.58.1","DOI":"10.1002\/cpns.25","volume":"79","author":"R Natarajan","year":"2017","unstructured":"Natarajan, R., Northrop, N. & Yamamoto, B. Fluorescein Isothiocyanate (FITC)-dextran extravasation as a measure of blood-brain barrier permeability. Curr. Protoc. Neurosci. 79, 9.58.1\u20139.58.15 (2017).","journal-title":"Curr. Protoc. Neurosci."},{"key":"64020_CR43","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1111\/j.1742-4658.2007.05755.x","volume":"274","author":"G Escames","year":"2007","unstructured":"Escames, G. et al. Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice. Febs J. 274, 2135\u20132147 (2007).","journal-title":"Febs J."},{"key":"64020_CR44","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/ALN.0b013e31819146a9","volume":"110","author":"Y Hatano","year":"2009","unstructured":"Hatano, Y. & Toda, H. Modulation of opioid actions by nitric oxide signaling. Anesthesiology 110, 166\u2013181 (2009).","journal-title":"Anesthesiology"},{"key":"64020_CR45","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1007\/s12274-022-4166-0","volume":"15","author":"M Sun","year":"2022","unstructured":"Sun, M. et al. Specific generation of nitric oxide in mitochondria of cancer cell for selective oncotherapy. Nano Res. 15, 5273\u20135278 (2022).","journal-title":"Nano Res."},{"key":"64020_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202110094","volume":"34","author":"Z Jiang","year":"2022","unstructured":"Jiang, Z. et al. Versatile polymer-initiating biomineralization for tumor blockade therapy. Adv. Mater. 34, e2110094 (2022).","journal-title":"Adv. Mater."},{"key":"64020_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202203291","volume":"35","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Acidity-triggered transformable polypeptide self-assembly to initiate tumor-specific biomineralization. Adv. Mater. 35, e2203291 (2023).","journal-title":"Adv. Mater."},{"key":"64020_CR48","doi-asserted-by":"publisher","first-page":"2101284","DOI":"10.1002\/adfm.202101284","volume":"31","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. Bioinspired tumor calcification enables early detection and elimination of lung cancer. Adv. Funct. Mater. 31, 2101284 (2021).","journal-title":"Adv. Funct. Mater."},{"key":"64020_CR49","doi-asserted-by":"publisher","first-page":"2007426","DOI":"10.1002\/adma.202007426","volume":"33","author":"P Zheng","year":"2021","unstructured":"Zheng, P. et al. A multichannel Ca2+ nanomodulator for multilevel mitochondrial destruction-mediated cancer therapy. Adv. Mater. 33, 2007426 (2021).","journal-title":"Adv. Mater."},{"key":"64020_CR50","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.1021\/acsnano.8b02034","volume":"12","author":"L Xu","year":"2018","unstructured":"Xu, L. et al. Enhanced intracellular Ca2+ nanogenerator for tumor-specific synergistic therapy via disruption of mitochondrial Ca2+ homeostasis and photothermal therapy. ACS Nano 12, 6806\u20136818 (2018).","journal-title":"ACS Nano"},{"key":"64020_CR51","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1021\/acs.accounts.5b00127","volume":"48","author":"S Banerjee","year":"2015","unstructured":"Banerjee, S. & Chakravarty, A. R. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity. Acc. Chem. Res. 48, 2075\u20132083 (2015).","journal-title":"Acc. Chem. Res."},{"key":"64020_CR52","doi-asserted-by":"publisher","first-page":"1701013","DOI":"10.1002\/adma.201701013","volume":"29","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. Core-satellite polydopamine-gadolinium-metallofullerene nanotheranostics for multimodal imaging guided combination cancer therapy. Adv. Mater. 29, 1701013 (2017).","journal-title":"Adv. Mater."},{"key":"64020_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202213765","volume":"61","author":"J Sun","year":"2022","unstructured":"Sun, J. et al. Dithiol-activated bioorthogonal chemistry for endoplasmic reticulum-targeted synergistic chemophototherapy. Angew. Chem. Int. Ed. 61, e202213765 (2022).","journal-title":"Angew. Chem. Int. Ed."},{"key":"64020_CR54","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1021\/acsnano.1c09048","volume":"16","author":"W Jiang","year":"2022","unstructured":"Jiang, W. et al. Nitric oxide induces immunogenic cell death and potentiates cancer immunotherapy. ACS Nano 16, 3881\u20133894 (2022).","journal-title":"ACS Nano"},{"key":"64020_CR55","doi-asserted-by":"publisher","first-page":"2008507","DOI":"10.1002\/adfm.202008507","volume":"31","author":"X Chu","year":"2021","unstructured":"Chu, X. et al. Nitric oxide modulating calcium store for Ca2+-initiated cancer therapy. Adv. Funct. Mater. 31, 2008507 (2021).","journal-title":"Adv. Funct. Mater."},{"key":"64020_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/cac2.12386","volume":"43","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination\/degradation of STAT1 in a GTP binding-dependent modality. Cancer Commun. 43, 123\u2013149 (2023).","journal-title":"Cancer Commun."},{"key":"64020_CR57","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41589-023-01512-1","volume":"20","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. CGI1746 targets \u03c31R to modulate ferroptosis through mitochondria-associated membranes. Nat. Chem. Biol. 20, 699\u2013709 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"64020_CR58","doi-asserted-by":"publisher","first-page":"2310218","DOI":"10.1002\/adma.202310218","volume":"36","author":"Z Ma","year":"2024","unstructured":"Ma, Z., Zeng, P., Zhai, T., Zhao, Y. & Liang, H. In situ mitochondrial biomineralization for drug-free cancer therapy. Adv. Mater. 36, 2310218 (2024).","journal-title":"Adv. Mater."},{"key":"64020_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310309","volume":"11","author":"Y Li","year":"2024","unstructured":"Li, Y., Liu, J., Chen, Y., Weichselbaum, R. R. & Lin, W. Nanoparticles synergize ferroptosis and cuproptosis to potentiate cancer immunotherapy. Adv. Sci. 11, e2310309 (2024).","journal-title":"Adv. Sci."},{"key":"64020_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202305923","volume":"20","author":"R Xu","year":"2024","unstructured":"Xu, R. et al. Remodeling of mitochondrial metabolism by a mitochondria-targeted RNAi nanoplatform for effective cancer therapy. Small 20, e2305923 (2024).","journal-title":"Small"},{"key":"64020_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1227\/01.neu.0000309458.92298.bb","volume":"57","author":"RJ Komotar","year":"2005","unstructured":"Komotar, R. J., Wilson, D. A. & Connolly, E. S. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. Neurosurgery 57, 7\u20138 (2005).","journal-title":"Neurosurgery"},{"key":"64020_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122479","volume":"306","author":"H Fei","year":"2024","unstructured":"Fei, H. et al. Gint4.T-siHDGF chimera-capped mesoporous silica nanoparticles encapsulating temozolomide for synergistic glioblastoma therapy. Biomaterials 306, 122479 (2024).","journal-title":"Biomaterials"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64020-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64020-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64020-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:07:28Z","timestamp":1760015248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64020-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64020"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64020-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6451662\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8990"}}